alendronate has been researched along with carbostyril in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andela, VB; O'Keefe, RJ; Puzas, EJ; Rosenblatt, JD; Rosier, RN; Schwarz, EM | 1 |
Aihara, E; Amagase, K; Hayashi, S; Kato, S; Takeuchi, K | 1 |
Aihara, E; Ohashi, Y; Takahashi, K; Takasuka, H; Takeuchi, K | 1 |
Naito, Y; Yoshikawa, T | 1 |
Crovella, S; De Leo, L; Decorti, G; Marcuzzi, A; Pontillo, A; Tommasini, A | 1 |
Amagase, K; Kato, S; Takeuchi, K | 1 |
KuliĆska, E; Laudy, AE; Tyski, S | 1 |
1 review(s) available for alendronate and carbostyril
Article | Year |
---|---|
Gastric ulcerogenic and healing impairment actions of alendronate, a nitrogen-containing bisphosphonate - prophylactic effects of rebamipide.
Topics: Alanine; Alendronate; Animals; Anti-Ulcer Agents; Bone Density Conservation Agents; Humans; Quinolones; Stomach Ulcer; Wound Healing | 2011 |
6 other study(ies) available for alendronate and carbostyril
Article | Year |
---|---|
Synergism of aminobisphosphonates and farnesyl transferase inhibitors on tumor metastasis.
Topics: Alendronate; Alkyl and Aryl Transferases; Animals; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Female; Flow Cytometry; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Quinolones; Tumor Cells, Cultured | 2002 |
Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.
Topics: Acetic Acid; Administration, Oral; Alanine; Alendronate; Animals; Anti-Ulcer Agents; Blotting, Western; Drug Interactions; Epithelium; Fibroblast Growth Factor 2; Gastric Mucosa; Male; Membrane Potentials; Quinolones; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stomach; Stomach Ulcer | 2007 |
Antral ulcers induced by alendronate, a nitrogen-containing biphophonate, in rat stomachs - prophylactic effect of rebamipide.
Topics: Alanine; Alendronate; Animals; Anti-Ulcer Agents; Antioxidants; Bone Density Conservation Agents; Dose-Response Relationship, Drug; Gastric Mucosa; Glutathione; Lipid Peroxidation; Male; Nitrogen; Pyloric Antrum; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Superoxide Dismutase | 2009 |
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Interactions; Gastritis; Helicobacter Infections; Humans; Male; Mice; Quinolones; Randomized Controlled Trials as Topic; Rats; Stomach Ulcer | 2010 |
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
Topics: Acyclic Monoterpenes; Alendronate; Animals; Anti-Inflammatory Agents; Cell Line; Child; Child, Preschool; Cholesterol; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Inflammation Mediators; Lovastatin; Male; Mevalonate Kinase Deficiency; Mice; Monocytes; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Polyenes; Polyisoprenyl Phosphates; Polyunsaturated Alkamides; Pyridines; Quinolones; Terpenes | 2011 |
The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
Topics: Acyclovir; Alendronate; Amitriptyline; Anti-Bacterial Agents; Atorvastatin; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Famotidine; Genes, MDR; Klebsiella pneumoniae; Magnesium Sulfate; Microbial Sensitivity Tests; Nicergoline; Pseudomonas aeruginosa; Quinolones; Salmonella; Ticlopidine | 2017 |